EC Number   |
Title |
Organism |
|---|
    1.14.14.1 | A tailor-made, self-sufficient and recyclable monooxygenase catalyst based on coimmobilized cytochrome P450 BM3 and glucose dehydrogenase |
Priestia megaterium |
| 1.14.14.1 | A tailor-made, self-sufficient and recyclable monooxygenase catalyst based on coimmobilized cytochrome P450 BM3 and glucose dehydrogenase |
Priestia megaterium DSM 32 |
| 1.14.14.1 | An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase |
Homo sapiens |
| 1.14.14.1 | Analysis and preliminary characterisation of the cytochrome P450 monooxygenases from Frankia sp. EuI1c (Frankia inefficax sp.) |
Frankia inefficax |
| 1.14.14.1 | Analysis and preliminary characterisation of the cytochrome P450 monooxygenases from Frankia sp. EuI1c (Frankia inefficax sp.) |
Frankia inefficax DSM 45817 |
| 1.14.14.1 | CH-activating oxidative hydroxylation of 1-tetralones and related compounds with high regio- and stereoselectivity |
Priestia megaterium |
| 1.14.14.1 | CH-activating oxidative hydroxylation of 1-tetralones and related compounds with high regio- and stereoselectivity |
Priestia megaterium ATCC 14581 |
| 1.14.14.1 | Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems |
Rattus norvegicus |
| 1.14.14.1 | Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization |
Homo sapiens |
| 1.14.14.1 | Differences in metabolism of the marine biotoxin okadaic acid by human and rat cytochrome P450 monooxygenases |
Homo sapiens |
